CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

autoimmune disease

lycera

Lycera Achieves First Milestone in Merck Research Collaboration

Lycera Corp., a biopharmaceutical company creating innovative approaches to developing novel oral medicines to treat autoimmune diseases, today announced that it has reached the first milestone under its research collaboration with Merck, triggering a milestone payment.

WWJ Newsradio 950–12/21/2011

The Van Andel Institute in Grand Rapids. Photo: Wikimedia Commons

New Use For Old Drug — Arthritis, Cancer And More, VARI Says

New research from the Grand Rapids-based Van Andel Research Institute demonstrates on the molecular level how the anti-malaria drug chloroquine represses inflammation, which may provide a blueprint for new strategies for treating auto-immune diseases from […]

WWJ Newsradio 950–07/18/2011

lycera

Lycera Announces Research Collaboration with Merck

The Plymouth-based biopharmaceutical developer Lycera Corp. Thursday announced an exclusive research collaboration with pharma giant Merck to develop drug candidates that have the potential to treat major autoimmune diseases such as rheumatoid arthritis, psoriasis, inflammatory bowel disease and multiple sclerosis

03/03/2011

“Secret” Symptoms Of Rheumatoid Arthritis

Pat Sweeting Reporting Can the pain in your joints be linked to difficulties with your vision? Yes, if the pain is caused by Rheumatoid Arthritis.

05/25/2010

Follow

Get every new post delivered to your Inbox.

Join 1,866 other followers